Portuguese Public Attitudes Regarding Contact Between Healthcare Professionals and Patient’s Relatives for Genetic Risk Disclosure: A Cross-Sectional Study
DOI:
https://doi.org/10.20344/amp.22204Keywords:
Aconselhamento Genético, Comunicação, Confidencialidade, Família, Pessoal de Saúde, Predisposição Genética para Doença, Relações Profissional-DoenteAbstract
Hereditary diseases can affect patients and their biological relatives, who may be at risk of developing these conditions or transmitting them to their descendants. This study explores the attitudes of a sample of Portuguese people towards receiving information about genetic risks and policies on the disclosure of such risks. An online survey using 5-point Likert scale statements (from 1 – “totally disagree” to 5 – “totally agree”) was distributed through social media and in public places, resulting in a sample of 1034 respondents with a mean (M) age of 38.58 (standard-deviation, SD = 14.91) years old; 75.4% were women, 74.4% had higher education, and 55.5% were childless. The main findings suggest that participants strongly prefer to be informed about genetic risks by a doctor rather than not being informed at all (M = 4.75; SD = 0.67), are less supportive of learning of genetic risks first by a close relative (M = 3.94; SD = 1.11), favor legislation allowing healthcare professionals to contact them even if their relatives do not wish to disclose the information (M = 4.47; SD = 0.87), and are less favorable towards laws requiring individuals to inform their direct family members of their genetic risks (M = 3.88; SD = 1.27). These findings could inform ongoing discussions about the roles and responsibilities of healthcare professionals in conveying relevant information to at-risk relatives.
Downloads
References
Lucassen A, Clarke A. In the family: access to, and communication of, familial information in clinical practice. Hum Genet. 2022;141:1053-8.
Ahsan MD, Levi SR, Webster EM, Bergeron H, Lin J, Narayan P, et al. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis. PEC Innov. 2023;17:100138.
Portugal. Law no. 12/2005. Official Gazette, I Series, no. 18 (2005/01/23). p. 606-11.
Menko FH, van der Velden SL, Griffioen DN, Moha DA, Jeanson KN, Hogervorst FB, et al. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. 2024;33:615-22.
Van Haecke DD, de Montgolfier S. Genetic diseases and information to relatives: practical and ethical issues for professionals after introduction of a legal framework in France. Eur J Hum Genet. 2018;26:786-95.
Andersson A, Hawranek C, Öfverholm A, Ehrencrona H, Grill K, Hajdarevic S, et al. Public support for healthcare-mediated disclosure of hereditary cancer risk information: results from a population-based survey in Sweden. Hered Cancer Clin Pract. 2020;18:18.
Tiller JM, Stott A, Finlay K, Boughtwood T, Madelli EO, Horton A, et al. Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public. Eur J
Hum Genet. 2023;32:98-108.
Phillips A, Dewitte I, Debruyne B, Vears D, Borry P. Disclosure of genetic risk in the family: a survey of the Flemish general population. Eur J Med Genet. 2023;66.
Pinto M, Freixo JP, Júlio F, Milagre TH, Sousa L, Sousa L, et al. Preferences of people with inherited genetic conditions and family members in Portugal toward informing at-risk relatives of genetic risk. Eur J Hum Genet. 2024;32:S3-90.
Mendes Á, Paneque M, Sequeiros J. Disclosure of genetic risk to family members: a qualitative study on healthcare professionals’ perceived roles and responsibilities. Eur J Med Genet. 2024;68:104931.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

